The BriefGet Up To Speed
Though organ transplantation has become a life-saving marvel of modern medicine, the donor waitlist is substantially longer than the supply, and many patients die before they can be treated. Thus, proponents claim, creating an economic incentive for organ donation will save lives. Others, however, argue that allowing the sale of harvested organs would decrease equity of access between the rich and poor and foster an illicit organ trade in developing nations. Should we legalize the market for human organs?
Lloyd R. Cohen
2 Items- Professor of Law at George Mason University
More from Lloyd R. CohenAmy L. Friedman
2 Items- M.D., Director of Transplantation and Professor of Surgery at SUNY Upstate Medical University
More from Amy L. FriedmanSally Satel
2 Items- M.D., Resident Scholar at AEI and a Psychiatrist at the Oasis Clinic in Washington, D.C.
More from Sally Satel
James F. Childress
2 Items- Hollingsworth Professor of Ethics at the University of Virginia
More from James F. ChildressFrancis L. Delmonico
2 Items- M.D., Professor of Surgery at Harvard Medical School and Director of Medical Affairs of The Transplantation Society (TTS)
More from Francis L. DelmonicoDavid Rothman
0 Items- Bernard Schoenberg Professor of Social Medicine and Director of the Center on Medicine as a Profession at Columbia
Arguments for Markets
Arguments against Markets
Wait List
Organ Trafficking/Transplant Tourism
Iran
Compensation in Other Markets
Cardiac-Death Donations
Non-Market Alternatives
UNOS
Harris/WSJ Poll